Retatrutide, a novel dual stimulator of the GLP-1 binding site and glucose-dependent released polypeptide (GIP) binding site , is showing promising results in initial human trials . Ongoing research https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/